Topics
Cardiovascular diseases
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030
Aletta E Schutte · Markus Schlaich
Blood pressure in young Aboriginal and Torres Strait Islander people: analysis of baseline data from a prospective cohort study
Reducing early cardiovascular risks, while avoiding deficit-framing, is critical for promoting cardiovascular health throughout life
Berhe W Sahle · Emily Banks · Robyn Williams · Grace Joshy · Garry Jennings · Jonathan C Craig · Nicholas G Larkins · Francine Eades · Rebecca Q Ivers · Sandra Eades
Clinical phenotype of COVID‐19 vaccine‐associated myocarditis in Victoria, 2021–22: a cross‐sectional study
A threefold or greater increase in troponin level may be a clinically useful predictor of cardiac MRI abnormalities
Julia Smith · Silja Schrader · Hannah Morgan · Priya Shenton · Annette Alafaci · Nicholas Cox · Andrew J Taylor · James Hare · Bryn Jones · Nigel W Crawford · Jim P Buttery · Hazel J Clothier · Daryl R Cheng
The cost of treating hypertension in Australia, 2012–22: an economic analysis
During 2012–22, about 40% of the cost of managing hypertension in Australia was borne directly by patients (about $494 million per year)
Emily R Atkins · Long Huy Nguyen · Mary Lou Chatterton · Markus Schlaich · Aletta E Schutte · Anthony Rodgers
Management of people after stroke in 383 Victorian general practices, 2014–2018: analysis of linked stroke registry and general practice data
The general practice management of people who have been hospitalised with stroke or TIA could be improved
Muideen T Olaiya · Joosup Kim · Christopher Pearce · Kiran Bam · Dominique A Cadilhac · Nadine E Andrew · Lauren M Sanders · Amanda G Thrift · Mark R Nelson · Seana Gall · Monique F Kilkenny
The national Cardiovascular Health Leadership Research Forum: a new data‐driven model placing research at the centre of improving patient outcomes
Harnessing research resources to tackle key health challenges can accelerate implementation and drive new preventive and therapeutic strategies, positively affecting patient and economic outcomes
For the Cardiovascular National Health Leaders Research Forum Writing Group
Notification of acute rheumatic fever and rheumatic heart disease in hospitalised people in the Midwest region of Western Australia, 2012–2022: retrospective administrative data analysis
Clinician awareness of notification requirements and automated technology that facilitates ARF/RHD notifications are needed
Ingrid Stacey · Yolande Knight · Claire MX Ong · Amy Lee · Suresh Karuppannan · Allison Christou · Judith M Katzenellenbogen
Genetic testing in cardiovascular disease
Michael P Gray · Gemma A Figtree
The national Cardiovascular Health Leadership Research Forum: a new data-driven model placing research at the centre of improving patient outcomes.
Each year, more than $14 billion is spent by the federal government on the direct health costs of cardiovascular disease, a leading cause of death and disability in Australia. A perspective in the Medical Journal of Australia discusses developing new models to harness Australia’s immense research resources to drive new strategies that can help patient and economic outcomes. “Australia urgently needs a model that connects governments, health service providers and the research workforce to regularly update data on the burden of disease and essential clinical quality indicators,” the authors state. “There is already a wealth of information available for clinical quality improvement, but these data are often fragmented, lack robust metadata and are unable to be accessed in a systematic and timely manner.” The Cardiovascular Health Leadership Research Forum (CV HLRF) connects the health system with Australia’s researchers. It allows funders to invest in, and our health system to implement, prioritised research areas. “Until now, there has been no mechanism that allows for a fully integrated national conversation on CVD [cardiovascular disease] and stroke between the health system, clinicians, researchers, industry partners, state and federal governments, and data and health economics experts.” “It has the potential to accelerate implementation and drive new preventive and therapeutic strategies and foster a vibrant medical technology ecosystem, thereby, positively affecting patient and economic outcomes,” the authors said. The CVHLRF was established in 2022 and was designed and is hosted by the Australian Cardiovascular Alliance (ACvA) — the nation’s peak body for CVD researchers. “Key elements of the CVHLRF include: endorsement by National Health Chief Executive Forum as a valuable model for connecting health, clinical and research leaders to contemporary cardiovascular health data to identify evidence-based research and implementation priorities;commitment of health leaders from all Commonwealth, state and territory health jurisdictions to at least biannual forum meetings;collaborative approach to identifying research and implementation priorities that are deeply relevant to health system needs for CVD;connection to national cardiovascular research workforce through the ACvA for whole-of-pipeline solutions (eg, fundamental mechanisms, new diagnostic and therapeutic tools, bioengineering, clinical trials, and implementation and policy);building of partnerships with health services and industry and moving towards co-commissioned approaches to prioritised areas;commitment to evaluating the clinical and economic impact of interventions prospectively; andsupport for an evolving national data dashboard of standardised cardiovascular outcomes and clinical quality indicators to identify major gaps and inequities.”Read the perspective published by the MJA here.
Sally Block
Non‐index hospital re‐admissions after hospitalisation with acute myocardial infarction and geographic remoteness, New South Wales, 2005–2020: a retrospective cohort study
Non-index hospital re-admission is associated with reduced mortality for people from regional or remote areas
Md Shajedur Rahman Shawon · Jennifer Yu · Art Sedrakyan · Sze‐Yuan Ooi · Louisa Jorm
Hospital costs for unplanned re‐admissions within 30 days of hospitalisations with heart failure, Australia, 2013–2017: a retrospective cohort study
Reducing the number of unplanned re-admissions could improve outcomes for people with heart failure and reduce hospital costs
Trang Dang · Wandy Chan · Sunnya Khawaja · James Fryar · Brenda Gannon · Sanjeewa Kularatna · William Parsonage · Isuru Ranasinghe
The health and economic burden of breathlessness, Australia, 2019: a national survey
Breathlessness imposes major burdens on individuals, the health care system, and the economy
Anthony P Sunjaya · Leanne M Poulos · Gian Luca Di Tanna · Thomas Lung · Guy B Marks · Helen K Reddel · Christine R Jenkins
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030
Key actions to be taken by the National Hypertension Taskforce, including a roadmap to help implement identified actions
Aletta E Schutte · Belinda Bennett · Clara K Chow · Geoffrey C Cloud · Kerry Doyle · Zoe Girdis · Jonathan Golledge · Andrew Goodman · Charlotte M Hespe · Meng P Hsu · Sharon James · Garry Jennings · Taskeen Khan · Audrey Lee · Lisa Murphy · Mark R Nelson · Stephen J Nicholls · Natalie Raffoul · Breonny Robson · Anthony Rodgers · Andrea Sanders · Catherine Shang · James E Sharman · Nigel P Stocks · Tim Usherwood · Ruth Webster · Jun Yang · Markus Schlaich
“Simply put: systems failed”: lessons from the Coroner's inquest into the rheumatic heart disease Doomadgee cluster
Queensland Health must act on the coronial recommendations to avoid more preventable deaths in Doomadgee
Avelina Tarrago (Wangkamahdla) · Ella Veit‐Prince · Claire E Brolan
First stroke incidence, causes, treatments, and outcomes for Aboriginal Peoples in South Australia and the Northern Territory: a pilot prospective study
A larger, population-based study of the incidence of stroke in Aboriginal people is both feasible and needed
Angela Dos Santos (Gumbaynggirr, Kwiamble) · Edmund Cheong · Anna H Balabanski · Kendall Goldsmith · Luke Burchill (Yorta Yorta, Dja Dja Wurrung) · James Burrow · Stephen Brady · Ferdous Alam · Mark Parsons · Judith M Katzenellenbogen · Amanda G Thrift · Timothy J Kleinig · Alex Brown (Wadi Wadi)
Dying of heart failure: how do we improve the experience?
Cardiologists require competency and confidence in managing not only deteriorating but also end of life, heart failure
Dominica Zentner · Vithoosharan Sivanathan · Jennifer Philip · Natasha Smallwood
Averting infections when implanting cardiac pacemakers and defibrillators
Documenting reasons for implanting CIEDs and detailed discussions with prospective patients about their risks are essential
William F Heddle AM
Factors associated with cardiac implantable electronic device‐related infections, New South Wales, 2016–21: a retrospective cohort study
Recognising specific risk factors for CIED-related infections is needed for informed decisions about procedures and prophylactic measures
Md Shajedur Rahman Shawon · Oluwadamisola T Sotade · Joan Li · Michelle D Hill · Liesl Strachan · Gabrielle Challis · Kate King · Sze‐Yuan Ooi · Louisa Jorm
Cardiovascular outcomes for people hospitalised with COVID‐19 in Australia, and the effect of vaccination: an observational cohort study
Clinical cardiovascular events were infrequent, and their likelihood was not influenced by COVID-19 vaccination
Hari P Sritharan · Kunwardeep S Bhatia · William Gaal · Leonard Kritharides · Clara K Chow · Ravinay Bhindi
Measurement of digoxin levels falsely affected by enzalutamide
A 75-year-old man presented with three days of lethargy and diarrhoea
Noor Lammoza · Maria Hormiz · Cherie Chiang · Chris Stead · Mustafa Ayhan · Samuel C Hume
2023 Australian guideline for assessing and managing cardiovascular disease risk
The 2023 Australian CVD guideline provides a pathway for early detection, clinical assessment and management of CVD risk
Mark R Nelson · Emily Banks · Alex Brown · Clara K Chow · David P Peiris · Nigel P Stocks · Rebecca Davies AO · Natalie Raffoul · Lisa Kalman · Emily Bradburn · Garry Jennings
Genetic testing in cardiovascular disease
Substantial advances have been made associating cardiovascular disease to markers of genetic risk
Michael P Gray · Diane Fatkin · Jodie Ingles · Elizabeth N Robertson · Gemma A Figtree
Catheter‐related superior vena cava syndrome: an increasing problem
A 16-year-old female patient with cystic fibrosis developed recurrent pleural effusions, facial plethora and prominent chest wall veins
John J Harvey · John I Vrazas · Elhamy Bekhit · Chris Barnes · Philip J Robinson
First implantable cardiac defibrillator insertions in New South Wales, 2005–2020: an analysis of linked administrative data
ICDs should be offered only to people for whom the potential benefit outweighs the potential harm
Lin Zhu · Andrew Hayen · Bianca Blanch · Nathan Engstrom · Jenny A Doust · Christopher Semsarian · Katy JL Bell
Presentations to selected Melbourne hospitals with cardiovascular disease by Indigenous and non‐Indigenous people, 2011–19: a linked administrative data analysis
Taking social health determinants into account is important for reducing the CVD burden for Indigenous Victorians
Eloise Price · Aneta Kotevski · Karen Lamb · Digsu Koye · Georgia Taylor · Gabrielle Ebsworth · Luke Burchill